Oct 27, 2022
Purissima, a leading, multi-patented health and wellness biotechnology company, announced today the official commercialization and sample availability of their Cannabichromene (CBC) in partnership with Open Book Extracts (OBX).
Read More
Sep 8, 2022
Purissima, a leading biotechnology health and wellness company, announced the completion of two separate ingredient testing programs with two leading contract research organizations. Testing included biological tests on human skin explants to reveal the effectiveness of Purissima's produced compounds Cannabichromene (CBC) and Cannabichromenic acid (CBCA).
Jul 19, 2022
Purissima is the first biotechnology company to achieve commercial scale production of minor cannabinoids using algae fermentation. In collaboration with Open Book Extracts, the company will officially commercialize before Fall 2022.
Jun 1, 2022
The company has proven the capacity to produce more than 70 compounds, many of which are hard to replicate minor cannabinoids as well as new plant-powered chemistries with high potential therapeutic value.
Apr 28, 2022
Businesses will inevitably rely on innovators like Purissima to offer pure and sustainable ingredients while accounting for scalability, product consistency, and resource traceability.
Mar 29, 2022
Further validates the platform’s technology advances in the fast-growing bioengineering industry.
Nov 14, 2019
Propietary platform allows for large-scale production of natural, high-demand ingredients for next-generation wellness.
